Therefore, we put forward the hypothesis that single nucleotide polymorphisms (SNPs) located within genes encoding the HVEM and CD160 molecules, as well as SNP–SNP interactions (between variations in genes encoding the receptor and ligand), are associated with ccRCC risk and outcomes. Here, CD160 is linked to nonpapillary renal cell carcinoma.